Showing 1 - 4 results of 4 for search 'B. Ferhanoglu', query time: 0.02s Refine Results
  1. 1
    PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA

    PB2074: IBRUTINIB AS A PROMISING TREATMENT FOR WALDENSTRÖM MACROGLOBULINEMIA by O. Ilhan, G. Cengiz Seval, F. Avcu, B. Ferhanoglu, M. Ozcan, G. Cetin, E. Kurtoglu, H. Yilmaz, F. Atalay, E. Gulturk, M. Nalcaci, M. Beksac

    Published 2022-06-01
    Get full text
    Article
  2. 2
    P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY

    P1227: POLATUZUMAB VEDOTIN, RITUXIMAB, AND BENDAMUSTINE COMBINATION IN RELAPSED OR REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: A REAL-WORLD DATA FROM TURKEY by M. S. Dal, B. Uncu Ulu, A. Uzay, O. M. Akay, S. Besisik, M. N. Yenerel, S. Celik, L. Kaynar, O. K. Yucel, B. Deveci, M. Sonmez, O. Mehtap, H. S. Bekoz, C. Sunu, O. Salim, T. Ulas, S. Karti, F. Altuntas, B. Ferhanoglu, T. Firatli Tuglular

    Published 2022-06-01
    Get full text
    Article
  3. 3
    P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES

    P1229: RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): REAL-LIFE EXPERIENCE ON 225 PATIENTS FROM 4 COUNTRIES by T. Vassilakopoulos, B. Ferhanoglu, N. A. Horowitz, J. Apostolidis, Z. Mellios, L. Kaynar, M. Zektser, A. Symeonidis, A. Piperidou, C. Kalpadaki, O. M. Akay, S. C. Atalar, A. Sayyed, E. Katodritou, T. Leonidopoulou, S. Papageorgiou, T. Tadmor, O. Gutwein, S. Karakatsanis, C. Ganzel, G. Karianakis, G. Isenberg, G. Gainaru, E. Vrakidou, M. Palassopoulou, M. Ozgur, M. Siakantaris, S. Paydas, P. Tsirigotis, M. Tsirogianni, E. Hatzimichael, T. F. Tuglular, C. Chatzidimitriou, A. Liaskas, M. A. Lefaki, N. Kanellias, P. Zikos, A. Koumarianou, A. Gafter-Gvili, M. Angelopoulou, T. Karmiris, R. Gurion

    Published 2022-06-01
    Get full text
    Article
  4. 4
    P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP

    P1178: THE APPLICABILITY OF PROGNOSTIC MODELS UNDER RITUXIMAB-DOSE-ADJUSTED EPOCH (R-DA-EPOCH) IN PRIMARY MEDIASTINAL LARGE B-CELL LYMPHOMA (PMLBCL): A COMPARISON WITH R-CHOP by Theodoros Vassilakopoulos, B Ferhanoglu, Na Horowitz, J Apostolidis, Z Mellios, Alexia Piperidou, L Kaynar, M Zektser, A Giotasmater, Dei Hospital, Msida Malta, A Symeonidis, C Kalpadakis, A Agathocleous, Om Akay, A Sayyed, Sc Atalar, E Katodritou, T Leonidopoulou, Sg Papageorgiou, T. Tadmor, O Gutwein, S Karakatsanis, C Ganzel, G. Karianakis, G. Y. Isenberg, G Gainaru, E. Vrakidou, M Palassopoulou, M Ozgur, Marina Siakantaris, S Paydas, P Tsirigotis, M Tsirogianni, E Hatzimichael, Tf Tugular, Jv Assimakopoulos, L Ligdi, A Liaskas, Maria Aikaterini Lefaki, P Labropoulou, A Kopsaftopoulou, E Verrou, M Kanellias, P Zikos, A Koumarianou, A Gafter-Gvili, M Bouzani, Mk Angelopoulou, T Karmiris, R Gurion

    Published 2023-08-01
    Get full text
    Article

Search Tools: